Display options
Cite
Rosenberg ME. Cell-based therapies in kidney disease. Kidney Int Suppl (2011). 2013;3(4):364-367doi: 10.1038/kisup.2013.78.
Rosenberg, M. E. (2013). Cell-based therapies in kidney disease. Kidney international supplements, 3(4), 364-367. https://doi.org/10.1038/kisup.2013.78
Rosenberg, Mark E. "Cell-based therapies in kidney disease." Kidney international supplements vol. 3,4 (2013): 364-367. doi: https://doi.org/10.1038/kisup.2013.78
Rosenberg ME. Cell-based therapies in kidney disease. Kidney Int Suppl (2011). 2013 Dec;3(4):364-367. doi: 10.1038/kisup.2013.78. PMID: 25019020; PMCID: PMC4089669.
Copy Download .nbib Format: NLM
Share it on

Kidney Int Suppl (2011). 2013 Dec;3(4):364-367. doi: 10.1038/kisup.2013.78.

Cell-based therapies in kidney disease.

Kidney international supplements

Mark E Rosenberg

Affiliations

  1. Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota Medical School , Minneapolis, Minnesota, USA.

PMID: 25019020 PMCID: PMC4089669 DOI: 10.1038/kisup.2013.78

Abstract

Cell-based therapy is an emerging field but one that has shown early promise for the treatment of human kidney diseases. The most widely used cell is the mesenchymal stem cell (MSC) given its ability to be harvested from bone marrow, expanded in culture, and used in allogeneic protocols. The beneficial effects of MSCs occur through differentiation-independent pathways that include increased cell survival and proliferation, decreased inflammation, and suppression of immune function. Acute kidney injury and kidney transplantation are the two conditions most frequently treated with MSC infusion. Although initial studies are promising, the long-term efficacy and safety of MSC infusion awaits further study.

Keywords: acute kidney injury; cell therapy; induction treatment; kidney regeneration; mesenchymal stem cells; mesenchymal stromal cells

References

  1. Am J Nephrol. 2012;35(6):531-9 - PubMed
  2. J Cell Mol Med. 2012 Dec;16(12):2935-49 - PubMed
  3. Nat Med. 2013 May;19(5):646-51 - PubMed
  4. Stem Cells Transl Med. 2013 Feb;2(2):107-11 - PubMed
  5. Am J Kidney Dis. 2012 Dec;60(6):1012-22 - PubMed
  6. J Am Soc Nephrol. 2007 Jun;18(6):1754-64 - PubMed
  7. Clin J Am Soc Nephrol. 2011 Feb;6(2):412-22 - PubMed
  8. FASEB J. 2007 Dec;21(14):3917-27 - PubMed
  9. Cell Stem Cell. 2008 Mar 6;2(3):284-91 - PubMed
  10. Cell Transplant. 2013;22(3):423-36 - PubMed
  11. Am J Nephrol. 2013;37(1):16-29 - PubMed
  12. Cell Prolif. 2013 Apr;46(2):121-6 - PubMed
  13. Cell Stem Cell. 2012 Jun 14;10(6):709-716 - PubMed
  14. Semin Dial. 2009 Nov-Dec;22(6):629-35 - PubMed
  15. PLoS One. 2012;7(6):e38746 - PubMed
  16. JAMA. 2012 Mar 21;307(11):1169-77 - PubMed
  17. Stem Cells. 2010 Mar 31;28(3):585-96 - PubMed
  18. Stem Cells. 2004;22(7):1128-33 - PubMed
  19. Curr Drug Targets. 2009 Dec;10(12):1227-34 - PubMed
  20. Transplant Proc. 2011 Dec;43(10):3573-6 - PubMed
  21. Annu Rev Med. 2008;59:311-25 - PubMed
  22. Kidney Int. 2013 Aug;84(2):256-64 - PubMed

Publication Types